Ability to source marijuana genetic material from outside Colorado Senate Bill 23-271, which went into effect in early 2024, aims to enhance Colorado’s marijuana industry. A key provision allows licensed marijuana cultivators to source “genetic material” from approved entities in other jurisdictions. Genetic material is defined as material used to propagate cannabis plants, including: Immature
Last year, I attended an Expert Seminar in Amsterdam on Cannabis Regulation, EU Drug Law, Trade Rules, and the UN Drug Control Treaties. A central topic focused on advancing full cannabis legalization while complying with EU law and international Drug Treaties. During the discussion, Czechia presented its three-pillar approach to cannabis regulation: (1) decriminalization (in
As the U.S. cannabis community awaits the resumption of the DEA’s administrative law hearing on rescheduling marijuana later this month, this blog will take a glimpse at the ever-dynamic global landscape of cannabis policy. While some countries may expand, retract, or maintain the progress seen in 2024, much attention will focus on the key developments
Growing Cannabis in Australia Though growing cannabis for personal use remains illegal in most Australian states and territories, growing for medicinal and scientific purposes was legalized under federal law in 2016. Under federal law, cultivation includes sowing seeds, planting, growing, tending, nurturing, harvesting, grafting, dividing, or transplanting a cannabis plant. Production is the separation of
Germany has legalized recreational cannabis Germany’s new laws legalize possession by adults of up to 25 grams (around 1 ounce) of cannabis for recreational use. It also allows for adults to grow up to three plants. Use is prohibited within 100 meters of the entrance to a playground or school. This part of the legislation
Cannabis investments are difficult enough when the investor is a U.S.-based person or entity. But things can get immensely more complicated when foreign investment is on the table. Today I want to highlight some of the top considerations for foreign investors and U.S. cannabis companies alike. 1. Legality could cause serious headaches To this day,
Australia is said to have one of the highest cannabis prevalence rates in the world and public attitudes to its use are shifting. North American, European and other cannabis companies looking for investment opportunities would do well to follow these shifts. Growing cannabis for medicinal and scientific purposes was legalized under federal law in 2016.
Two of our international cannabis lawyers, Vince Sliwoski (business) and Adams Lee (international trade), recently joined the Simply Trade podcast for a lively discussion on the international cannabis trade. You can hear that free-ranging, informative conversation at either of the following links: Apple Podcasts Spotify As explained in the Simply Trade show notes: This episode
We are seeing in an uptick in China-related matters involving cannabis brands. Here are three tips for cannabis brands that are getting their products made in China: 1. Sign a Contract As I recently wrote in our sister blog, “while having a contract provides no guarantee of smooth operations or favorable dispute resolution, a well-drafted
Cannabis Brands and China Challenges Cannabis brands account for a sizeable component of my law firm’s intellectual property work (and, indeed, our work generally). Historically, there has been little overlap between our cannabis and China practice areas, beyond our representing a number of cannabis ancillary product companies on their China manufacturing matters. This is starting to change,
